Hemogenyx Pharmaceuticals PLC Announces Change of Registered Office
Hemogenyx Pharmaceuticals plc has officially changed its registered office address to 6th Floor, 60 Gracechurch Street, London, EC3V 0HR, effective immediately. This relocation aims to enhance operational efficiency and accessibility. Hemogenyx continues to focus on developing innovative treatments for blood diseases, with its corporate governance structure remaining intact. The announcement reflects the company’s commitment to maintaining a professional presence in a key financial district in London.
- Change of registered office address may enhance operational efficiency.
- Maintains presence in a key financial district in London.
- None.
LONDON, ENGLAND / ACCESSWIRE / July 1, 2022 / Hemogenyx Pharmaceuticals plc announces that its registered office address has changed with immediate effect to 6th Floor,60 Gracechurch Street, London, EC3V 0HR,United Kingdom.
Enquiries:
Hemogenyx Pharmaceuticals plc | https://hemogenyx.com |
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | headquarters@hemogenyx.com |
Peter Redmond, Director | peter.redmond@hemogenyx.com |
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
Matthew Johnson, Vadim Alexandre, Adam Cowl | |
Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
Lucy Williams, Duncan Vasey, Charles Goodfellow | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Hemogenyx Pharmaceuticals PLC
View source version on accesswire.com:
https://www.accesswire.com/707313/Hemogenyx-Pharmaceuticals-PLC-Announces-Change-of-Registered-Office
